MBM Holding, in partnership with Portland Holdings Investco Limited, is exploring coinvestment opportunities in nuclear medicine and radionuclide therapy (TRT), an innovative cancer treatment. This collaboration highlights MBM Holding’s commitment to advancing healthcare and fostering global innovation.
A key example of this commitment is the MBM-BHCC alliance, a partnership with the Beverly Hills Cancer Center in California. As the first and only subsidiary of the center in Dubai, this collaboration brings world-class expertise and cutting-edge treatments to the region. With a team of globally recognized specialists, MBM Holding delivers advanced, tailored cancer treatments in a healing environment that supports recovery. The company also leads groundbreaking clinical trials, ensuring continued progress in oncology and life-changing healthcare solutions.